Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117389 · ClinicalTrials.gov registry record
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
A clinical trial of Human Papillomavirus, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 587
- Enrollment target
- 1
- Study location
NCT01117389 is a study of Human Papillomavirus that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 587 participants, below the 26,033-participant average among 12 other Human Papillomavirus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01117389, a study of Human Papillomavirus, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 587 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will focus on the primary objectives: * To estimate the prevalence of HPV vaccination among a large cohort of childhood cancer survivors and an acquaintance control group. * To describe the difference in HPV vaccination rate and HPV vaccination intent among preadolescent/adolescent females surviving childhood cancer and an acquaintance control group. This study will also focus on the secondary objectives: * To examine sociodemographic, medical, and psychological differences between those who have/have not initiated HPV vaccination and between those who do/do not intend to get vaccinated in the future. * To assess the general predictive influence of sociodemographic, medical, and psychological variables on HPV vaccination and intent among mothers with preadolescent/adolescent daughters.
Conditions Studied
Study Locations (1)
Tennessee
- St . Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 587 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117389
The ClinicalTrials.gov registry entry for NCT01117389 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 587 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,033-participant average among 12 other Human Papillomavirus trials with a reported enrollment target (98% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Papillomavirus appearing as the primary indexed condition, and to 0 interventions.
NCT01117389 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01117389 about?
NCT01117389 is a clinical study titled "Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer". This study will focus on the primary objectives: * To estimate the prevalence of HPV vaccination among a large cohort of childhood cancer survivors and an acquaintance control group. * To describe the difference in HPV vaccination rate and HPV vaccination intent among preadolescent/adolescent femal...
What is the current status of trial NCT01117389?
This trial is currently completed. The enrollment target is 587 participants. The study started on 2010-05. Estimated completion is 2012-11.
What conditions does trial NCT01117389 study?
This clinical trial studies the following conditions: Human Papillomavirus.
Who is sponsoring clinical trial NCT01117389?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01117389 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
RECRUITING
-
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
RECRUITING · Phase 4
-
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
RECRUITING
-
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
ACTIVE NOT RECRUITING · Phase 1
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.